Mind, Brain, and Drug: An Introduction to PsychopharmacologyCovering the basic principles of psychopharmacology, this textbook presents psychopharmacology and drugs of abuse in a readily understood manner. With all of the latest research and a straightforward, engaging writing style, Hedges offers complete coverage of the field without being unnecessarily detailed--and, as a result, provides students with a thorough introduction to this increasingly important area. |
From inside the book
Results 1-3 of 78
Page 238
... ( Grof , 2003 ; Kahn & Chaplan , 2002 ) . Additionally , some of the newer , second - generation antipsychotics are seeing increasing use in bipolar disorder ( Kahn & Chaplan , 2002 ) ; 238 CHAPTER The Mood Stabilizers.
... ( Grof , 2003 ; Kahn & Chaplan , 2002 ) . Additionally , some of the newer , second - generation antipsychotics are seeing increasing use in bipolar disorder ( Kahn & Chaplan , 2002 ) ; 238 CHAPTER The Mood Stabilizers.
Page 250
... appear to have at least some therapeutic ef- fect in bipolar disorder ( Wisner et al . , 2002 ) , although additional research is needed to fully understand the role of the calcium - 250 CHAPTER TEN OTHER NONANTICONVULSANT MOOD STABILIZERS.
... appear to have at least some therapeutic ef- fect in bipolar disorder ( Wisner et al . , 2002 ) , although additional research is needed to fully understand the role of the calcium - 250 CHAPTER TEN OTHER NONANTICONVULSANT MOOD STABILIZERS.
Page 251
... mood - stabilizing properties ( Malhi & Berk , 2002 ) . Limited data suggest that the cholinesterase inhibitor ( by blocking cholinesterase , acetylcholine levels in the brain are increased ) ... MOOD STABILIZERS 251 SUMMARY STUDY QUESTIONS.
... mood - stabilizing properties ( Malhi & Berk , 2002 ) . Limited data suggest that the cholinesterase inhibitor ( by blocking cholinesterase , acetylcholine levels in the brain are increased ) ... MOOD STABILIZERS 251 SUMMARY STUDY QUESTIONS.
Common terms and phrases
abnormalities abuse acetylcholine action potential addition ADHD adverse effects agonist alcohol Alzheimer's disease American Journal amphetamines antagonism anticonvulsant antidepressants anxiety disorder appears associated atypical antipsychotics axons barbiturates behavioral benzodiazepines bipolar disorder blood body brain bupropion buspirone caffeine cannabinoid cell Clinical Psychiatry clozapine cocaine cognitive concentrations cortex cytochrome P450 dementia dopamine dose Drug-Drug Interactions efficacy enzymes example factors fluoxetine function GABA ginkgo glutamate half-life hippocampal hyperactivity disorder increased inhibit insomnia involved John's wort Journal of Clinical Journal of Psychiatry kava lithium major depression marijuana mechanism of action medications metabolism methadone methylphenidate mirtazapine modafinil monoamine oxidase mood stabilizers nervous system neurobiology neurons Neuroscience neurotransmitter nicotine norepinephrine occur opiate opioid pain panic disorder patients Pharmacokinetics Pharmacology presynaptic Psychopharmacology psychosis result role schizophrenia seizure serotonin side effects social phobia SSRIs stimulation supplement symptoms synapse syndrome TCAs therapeutic therapy tion toxicity treatment typical antipsychotics valerian valproic acid venlafaxine withdrawal